Literature DB >> 11514692

Non-invasive ventilation in acute exacerbations of chronic obstructive pulmonary disease: long term survival and predictors of in-hospital outcome.

P K Plant1, J L Owen, M W Elliott.   

Abstract

BACKGROUND: Non-invasive ventilation (NIV) reduces the need for intubation and the mortality associated with an exacerbation of chronic obstructive pulmonary disease (COPD). This study aimed to identify factors that could be used to stratify patients according to their risk of requiring invasive mechanical ventilation. The second aim was to determine the long term survival of patients treated with and without NIV.
METHODS: In this prospective multicentre randomised controlled trial 118 patients were allocated to standard treatment and 118 to NIV between November 1996 and September 1998. Arterial blood gas tensions and respiratory rate were recorded at enrolment and after 1 and 4 hours. Prognostic factors were identified using logistic regression analysis. All patients were followed until death or 1 January 1999.
RESULTS: At enrolment the H(+) concentration (OR 1.22 per nmol/l, 95% CI 1.09 to 1.37, p<0.01) and PaCO2 (OR 1.14 per kPa, 95% CI 1.14 to 1.81, p<0.01) were associated with treatment failure. Allocation to NIV was protective (OR 0.39, 95% CI 0.19 to 0.80). After 4 hours of treatment improvement in acidosis (OR 0.89 per nmol/l, 95% CI 0.82 to 0.97, p<0.01) and fall in respiratory rate (OR 0.92 per breaths/min, 95% CI 0.84 to 0.99, p=0.04) were associated with success. Median length of survival was 16.8 months in those treated with NIV and 13.4 months in those receiving standard treatment (p=0.12). The trend in improved survival was attributable to prevention of death during the index admission.
CONCLUSION: Initial pH and hypercapnia can be used to stratify groups of patients according to their risk of needing intubation. NIV reduces this risk and progress should be monitored using change in respiratory rate and pH. The long term survival after NIV is sufficiently good to render treatment appropriate.

Entities:  

Mesh:

Year:  2001        PMID: 11514692      PMCID: PMC1746126          DOI: 10.1136/thorax.56.9.708

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  26 in total

1.  Sequential use of noninvasive pressure support ventilation for acute exacerbations of COPD.

Authors:  G Hilbert; D Gruson; G Gbikpi-Benissan; J P Cardinaud
Journal:  Intensive Care Med       Date:  1997-09       Impact factor: 17.440

2.  Early use of non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease on general respiratory wards: a multicentre randomised controlled trial.

Authors:  P K Plant; J L Owen; M W Elliott
Journal:  Lancet       Date:  2000-06-03       Impact factor: 79.321

3.  The use of noninvasive positive pressure ventilation in the emergency department: results of a randomized clinical trial.

Authors:  K A Wood; L Lewis; B Von Harz; M H Kollef
Journal:  Chest       Date:  1998-05       Impact factor: 9.410

4.  Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments)

Authors:  A F Connors; N V Dawson; C Thomas; F E Harrell; N Desbiens; W J Fulkerson; P Kussin; P Bellamy; L Goldman; W A Knaus
Journal:  Am J Respir Crit Care Med       Date:  1996-10       Impact factor: 21.405

5.  A randomized, prospective evaluation of noninvasive ventilation for acute respiratory failure.

Authors:  T J Martin; J D Hovis; J P Costantino; M I Bierman; M P Donahoe; R M Rogers; J W Kreit; F C Sciurba; R A Stiller; M H Sanders
Journal:  Am J Respir Crit Care Med       Date:  2000-03       Impact factor: 21.405

6.  Nasal ventilation in COPD exacerbations: early and late results of a prospective, controlled study.

Authors:  G Bardi; R Pierotello; M Desideri; L Valdisserri; M Bottai; A Palla
Journal:  Eur Respir J       Date:  2000-01       Impact factor: 16.671

7.  Comparison of the acute effects on gas exchange of nasal ventilation and doxapram in exacerbations of chronic obstructive pulmonary disease.

Authors:  R M Angus; A A Ahmed; L J Fenwick; A J Peacock
Journal:  Thorax       Date:  1996-10       Impact factor: 9.139

8.  Randomised controlled trial of nasal ventilation in acute ventilatory failure due to chronic obstructive airways disease.

Authors:  J Bott; M P Carroll; J H Conway; S E Keilty; E M Ward; A M Brown; E A Paul; M W Elliott; R C Godfrey; J A Wedzicha; J Moxham
Journal:  Lancet       Date:  1993-06-19       Impact factor: 79.321

9.  Comparison of noninvasive positive pressure ventilation with standard medical therapy in hypercapnic acute respiratory failure.

Authors:  T Celikel; M Sungur; B Ceyhan; S Karakurt
Journal:  Chest       Date:  1998-12       Impact factor: 9.410

10.  Acute hypercapnic respiratory failure in patients with chronic obstructive lung disease: risk factors and use of guidelines for management.

Authors:  A A Jeffrey; P M Warren; D C Flenley
Journal:  Thorax       Date:  1992-01       Impact factor: 9.139

View more
  58 in total

Review 1.  Management of an acute exacerbation of copd: are we ignoring the evidence?

Authors:  M K Johnson; R D Stevenson
Journal:  Thorax       Date:  2002-10       Impact factor: 9.139

2.  Early failure of noninvasive ventilation in chronic obstructive pulmonary disease with acute hypercapnic respiratory failure.

Authors:  Byuk Sung Ko; Shin Ahn; Kyung Soo Lim; Won Young Kim; Yoon-Seon Lee; Jae Ho Lee
Journal:  Intern Emerg Med       Date:  2015-09-04       Impact factor: 3.397

3.  Tight glycaemic control in acute exacerbations of COPD.

Authors:  S J Finney; T W Evans
Journal:  Thorax       Date:  2006-04       Impact factor: 9.139

Review 4.  Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure.

Authors:  Bram Rochwerg; Laurent Brochard; Mark W Elliott; Dean Hess; Nicholas S Hill; Stefano Nava; Paolo Navalesi; Massimo Antonelli; Jan Brozek; Giorgio Conti; Miquel Ferrer; Kalpalatha Guntupalli; Samir Jaber; Sean Keenan; Jordi Mancebo; Sangeeta Mehta; Suhail Raoof
Journal:  Eur Respir J       Date:  2017-08-31       Impact factor: 16.671

5.  Noninvasive ventilation in hypercapnic acute respiratory failure due to chronic obstructive pulmonary disease vs. other conditions: effectiveness and predictors of failure.

Authors:  Jason Phua; Kien Kong; Kang Hoe Lee; Liang Shen; T K Lim
Journal:  Intensive Care Med       Date:  2005-03-02       Impact factor: 17.440

6.  Domiciliary non-invasive ventilation for recurrent acidotic exacerbations of COPD: an economic analysis.

Authors:  J M Tuggey; P K Plant; M W Elliott
Journal:  Thorax       Date:  2003-10       Impact factor: 9.139

Review 7.  Acute exacerbations in chronic obstructive pulmonary disease: current strategies with pharmacological therapy.

Authors:  Charles S Hall; Andreas Kyprianou; Alan M Fein
Journal:  Drugs       Date:  2003       Impact factor: 9.546

8.  Co-morbidity and acute decompensations of COPD requiring non-invasive positive-pressure ventilation.

Authors:  Raffaele Scala; Sandra Bartolucci; Mario Naldi; Marcello Rossi; Mark W Elliott
Journal:  Intensive Care Med       Date:  2004-07-17       Impact factor: 17.440

Review 9.  Treatment of chronic obstructive pulmonary disease in older patients: a practical guide.

Authors:  Abebaw M Yohannes; Christopher C Hardy
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

10.  [Non-invasive ventilation as treatment for acute respiratory insufficiency. Essentials from the new S3 guidelines].

Authors:  B Schönhofer; R Kuhlen; P Neumann; M Westhoff; C Berndt; H Sitter
Journal:  Anaesthesist       Date:  2008-11       Impact factor: 1.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.